AGOMAVAL

This brand name is authorized in Germany, Malta

Active ingredients

The drug AGOMAVAL contains one active pharmaceutical ingredient (API):

1 Agomelatine UNII A17BS39YWR - AGOMELATINE CITRIC ACID

Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist. In humans, agomelatine has positive phase shifting properties; it induces a phase advance of sleep, body temperature decline and melatonin onset. Read about Agomelatine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AGOMAVAL Film-coated tablet	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06AX22	Agomelatine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 14439142, 14439159
Country: MT	Medicines Authority	Identifier(s): MA982/03001